| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/10/2002 | WO2001046213A3 Compound comprising a peptide moiety and an organo-silane moiety. |
| 05/10/2002 | WO2001044817A3 Fluorescence correlation spectroscopy to identify compound-target binding |
| 05/10/2002 | WO2001044496A3 Protease-activated receptor (par) modulator assays |
| 05/10/2002 | WO2001042781A3 Supracolonic aerodigestive neoplasm detection |
| 05/10/2002 | WO2001042472A3 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 05/10/2002 | WO2001042451A3 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 05/10/2002 | WO2001040511A3 Detection system |
| 05/10/2002 | WO2001040478A3 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
| 05/10/2002 | WO2001040466A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/10/2002 | WO2001038587A3 Energy-transfer assay for polynucleic acid polymerases |
| 05/10/2002 | WO2001038511A3 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/10/2002 | WO2001036673A3 Test for micro-organisms |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036618A3 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001034849A9 Apparatus and method for disease detection |
| 05/10/2002 | WO2001034842A9 Pcr amplification on microarrays of gel immobilized oligonucleotides |
| 05/10/2002 | WO2001034772A9 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/10/2002 | WO2001033199A3 Universal fluorescent sensors |
| 05/10/2002 | WO2001032930A9 Methods and apparatuses for analyzing polynucleotide sequences |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001029266A9 Identification of arsacs mutations and methods of use therefor |
| 05/10/2002 | WO2001028580A3 Modulation of angiogenesis |
| 05/10/2002 | WO2001027326A3 Template-dependent ligation with pna-dna chimeric probes |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 05/10/2002 | WO2001023533A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 05/10/2002 | WO2001020044A3 Signal counting for in situ hybridization |
| 05/10/2002 | WO2001013787A3 Method for predicting clinical outcome after reperfusion therapy |
| 05/10/2002 | WO2001006011A3 Arrays comprising non-covalently associated nucleic acid probes and methods for making and using them |
| 05/10/2002 | WO2001000877A3 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 05/10/2002 | WO2000073507A3 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000063443A3 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000055373A9 Methods of screening for macrophage development modulators |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | WO2000046407A3 Methods of utilizing the tt virus |
| 05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427747A1 Affinity maturation by competitive selection |
| 05/10/2002 | CA2427523A1 Predicting agent for metastasis |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427474A1 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | CA2427436A1 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | CA2427267A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | CA2427223A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 05/10/2002 | CA2427214A1 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | CA2426658A1 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | CA2426571A1 Detection of ovarian cancer |
| 05/10/2002 | CA2426446A1 Detection of binding species with colloidal and non-colloidal structures |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | CA2425583A1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 05/10/2002 | CA2424932A1 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | CA2388548A1 System, method, and computer software product for linked window interfaces |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020056146 Expression vector for use in generation of trangenic animals; for use in animal modeling of disease |
| 05/09/2002 | US20020055628 Nucleotide sequences for use in the detection of preferential microorganisms and classification of anthrax |
| 05/09/2002 | US20020055624 Polypeptide for use in the treatment of inflammation, graft vs host disease, sepsis, tumors and metastasis |
| 05/09/2002 | US20020055515 Contacting stimulated cells with a candidate compound which is an inhibitor of ATP binding to a P2Y- purinoceptor; and assaying said cells for release of one or more mediators. |
| 05/09/2002 | US20020055478 Monitoring 103P3E8 gene products in a biological sample from a patient who has or who is suspected of having cancer and comparing the gene expression products with that of a normal sample |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055470 Administering a nucleoside analog such AZT or ganciclovir to prevent resistance of tumor cells to chemotherapeutic agents, methotrexate or radiotherapy |
| 05/09/2002 | US20020055189 Propagating microorganism; mix nutrient broth, inoculate with cells, infect with preferential viruss, recover viral particles |
| 05/09/2002 | US20020055181 Light generating compound for use in the detection of preferential particles in sample |
| 05/09/2002 | US20020055163 Amino acid sequences of peptides that are encoded by genes within the human genome, the protease peptides; useful in the development of human therapeutics and diagnostic formulations |
| 05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/09/2002 | US20020055149 Inefficient fast PCR |
| 05/09/2002 | US20020055146 Control of the expression of anchored genes using micron scale heaters |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055141 Genetically engineered microorgaism for use as diagnostic tool |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020055138 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 05/09/2002 | US20020055137 Methods for detecting nucleic acid molecules encoding flh2882, a GPCR showing homology to the 5HT family of receptors |
| 05/09/2002 | US20020055134 Detecting the total cell count in a sample, contacting cells with molecule or dye that is detectably altered by enzymatic activity of a viable cell, detecting the dye or molecule, thereby detecting viable cell number, comparing with total |
| 05/09/2002 | US20020055128 Measuring binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein by means of a label associated with candidate compound, measuring binding, testing signal generated |
| 05/09/2002 | US20020055127 Method for continuous Immunoassay monitoring |
| 05/09/2002 | US20020055125 A solid substrate having planar surface; a plurality of different protein-binding agents bound to the substrate, each comprises achoring segment stably bound to the substrate surface, a peptidomimetic protein binding segment, a linker |
| 05/09/2002 | US20020055123 Screening method for identifying ligands for target proteins |
| 05/09/2002 | US20020055120 Device and process for the determination and/or removal of a substance in a sample |
| 05/09/2002 | US20020055119 Polynucleotide separation method and apparatus therefor |
| 05/09/2002 | US20020055117 Methods for detecting prostate cancer |
| 05/09/2002 | US20020055116 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 05/09/2002 | US20020055113 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 05/09/2002 | US20020055110 Matrix screening method |
| 05/09/2002 | US20020055109 Single-stranded trap using a single-strand binding protein |
| 05/09/2002 | US20020055107 Cancer diagnosis method using cell growth inhibiting and cell differentiation specific SYG972 gene and genomic DNA and promoter thereof |
| 05/09/2002 | US20020055104 Contacting the nucleic acid molecule with a ligand, under conditions suitable for sequence-dependent binding and treating with a modifying agent |
| 05/09/2002 | US20020055103 Adherence and/or crosslinking to immobilized DNA duplexes at different separations from an electrode and probed to detect and localize genetic point mutations and other base-stacking perturbations of within an oligonucleotide |
| 05/09/2002 | US20020055101 Oligonucleotide sequences which can be used as probes or amplification primers for polymerase chain reaction |
| 05/09/2002 | US20020055100 Labelled nucleotides incorporated stepwise in a nucleic acid molecule by primer extension |
| 05/09/2002 | US20020055099 Sequential cdna library and uses thereof |
| 05/09/2002 | US20020055097 Comparing the levels of transcription of RNA transcripts from cells of known normal tissue and suspected mutant or cancer cells |
| 05/09/2002 | US20020055096 Determining the loss of heterozygosity at chromosome 3p24 in tissue |
| 05/09/2002 | US20020055095 Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations |
| 05/09/2002 | US20020055094 Method of detection of influenza virus and compounds for use therein |
| 05/09/2002 | US20020055092 Administering a contrast agent to a viable sample, acquiring a test data set and comparing to a comparison data set to assess the response |